Curie-Cancer and Meiogenix Sign Two Partnership Agreements

News   Nov 19, 2013

 
Curie-Cancer and Meiogenix Sign Two Partnership Agreements
 
 
 
 

RELATED ARTICLES

Taking the Genomic Revolution to Corn Fields to Improve Crops

News

Researchers want to understand what it is that makes certain plants more adapted to stressful environments than other plants.

READ MORE

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News

TheFDA has changed its accelerated approval of blinatumomab (Blincyto®) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE